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Absorption spectra of colchicine and its analogues are affected by the presence of the B-ring, although it 
is not part of the chromophore (C-ring). Thus, 2-methoxy-5-(2',3'4'-trimethoxyphenyl)tropone has absorp- 
-tion maxima t 341 nm, whereas that of desacetamidocolchicine is at 353 nm. A similar red shift in the 
~.max of colchicine, desacetamidocolchicine a d2-methoxy-(2',3',4'-trimethoxyphenyl)tropone also occurs 
when they are immobilized in the binding site to tubulin or in pure glycerol. We also observed that the 
B-ring of colchicine alone or with substituent does not affect he U'V-induced rearrangement of colchicine 
to lumicolchicine. However, in the absence of the B-ring, as in the case of 2-methoxy-5-(2',3'4'-trimethoxy- 
phenyl)tropone, the rearrangement reaction of the C-ring slows down significantly. 
Colchicine analog; Tubulin; Absorption spectrum 
1. INTRODUCTION 
The importance of the B-ring of colchicine in its 
binding to tubulin has been emphasized by dif- 
ferent laboratories [1-8]. It has been observed that 
several properties of the colchicine-tubulin terac- 
tion such as the association rate, reversibility and 
the promotion of drug fluorescence are related to 
the B-ring of colchicine [7]. Recently significant 
differences in the binding and thermodynamic 
parameters such as activation energy, entropy and 
enthalpy have been reported for colehicine and 
2-methoxy-5-(2' ,3' ,4' -trimethoxyphenyl)tropone 
(called AC because it lacks the B-ring of col- 
chicine, see fig.l) [5,6]. Studies on B-ring 
analogues of colchicine are also interesting from 
the clinical point of view. Thus, Capraro and 
Brossi [8] synthesized a variety of interesting B- 
ring analogues to determine the structural entities 
needed for optimal biological effects such as 
tubulin-binding activity and antileukemic activity 
with minimum level of toxicity. 
This B-ring is a seven-membered saturated ring 
of colchicine (with a side chain at the C-7 position, 
see fig. 1) and has no chromophore to show absorp- 
tion in the visible region. Here, we observed that 
the presence of the B-ring has a significant effect 
on the absorption spectra of the C-ring as well as 
on the photo-induced rearrangement of the C-ring. 
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2. MATERIALS AND METHODS 
Colchicine and GTP were products of Sigma. 
Desacetamidocolchicine and 2-methoxy-5-(2' ,3' ,  
4' -trimethoxyphenyl)tropone were kind gifts of Dr 
T.J .  Fitzgerald, Florida A and M University. All 
other chemicals used were reagent grade. 
Tubulin was prepared by phosphocellulose 
chromatography of goat brain microtubule pro- 
tein, prepared by two cycles of temperature- 
dependent polymerization [9]. Protein was stored 
in liquid nitrogen in tubulin assembly buffer 
[0.1 M Mes (pH 7.0), 0.5 mM MgCI2, 1 mM 
EGTA, 0.1 mM GTP]. The same assembly buffer 
without GTP was used for binding experiments o 
prevent polymerization. Protein was estimated ac- 
cording to Lowry et al. [10] using BSA as a 
standard. 
Absorption spectra were obtained on a Cary 
model 17D recording spectrophotometer. For 
ultraviolet irradiation of free drug, each com- 
pound dissolved in 95°70 ethanol in a 1 ml quartz 
cuvette (1 cm light path) was placed exactly 2.5 cm 
from the UV lamp (model UV 4-11; Ultraviolet 
Products, San Gabriel, CA) in a dark room. After 
each irradiation the absorbance was measured at 
350 nm. Bound drug was irradiated under identical 
conditions after the drug-tubulin complex was 
formed on incubation at 37°C for 30min. 
Fluorescence measurements were made with a 
Perkin-Elmer MPF 44B spectrofluorometer. 
3. RESULTS AND DISCUSSION 
3.1. Effect of the B-ring on the absorption spectra 
of the C-ring of colchicine 
Absorption spectra of colchicine and its 
analogues can be divided into two parts: a UV part 
ranging from 200 to 300 nm having a high extinc- 
tion coefficient (e) of 104-105 and the other 
overlap both UV and visible regions ranging from 
300 to 400 nm and a little weaker in intensity (e - 
1.5-1.8 x 104). Colchicine and all its analogues 
discussed here have C = O (at the C-ring) and C = C 
(of the A- and C-rings) conjugated with each 
other. Two absorption bands observed in the case 
of colchicine (fig.2A) are related on ~--electrons ex- 
tending from the A- to C-ring and are strong in in- 
tensity (e > 104 ) and no band related to the 
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Fig.2. (A) Ultraviolet absorption spectra of colchicine 
(2.27 x 10 -6 M) in water. Absorption maxima: Amaxl = 
247 nm; Amax2 = 353 nm. (B) Absorption spectra of 
colchicine (2.7 x 10-6M), desacetamidocolchicine 
(2.8 x 10 -6M) and AC compound (3 × 10 -6M) in 
assembly buffer. (1) Colchicine, Amax = 353 nm; (2) 
desacetamidocolchicine, Amax = 353 nm; (3) AC 
compound, Amax = 341 nm. 
nonbonding molecular orbital, largely localized on 
the oxygen atom with weaker intensity (e - 10 ~) is 
seen. Band 2 represents he absorption property of 
the C-ring. Fig.2B shows the visible absorption 
spectra of colchicine, desacetamidocolchicine a d 
AC in water. The values Of the extinction coeffi- 
cients are very similar for each compound. Col- 
chicine and desacetamidocolchicine have absorp- 
tion maxima at 353 nm whereas in the case of AC, 
it is at 341 nm. This significant red shift (341 to 
353 nm) in the absorption spectra of desacetami- 
docolchicine or chicine is due to the presence of an 
alicyclic B-ring in the molecule. The question 
which thus arose was how the presence of this ring 
which is not a part of the conjugation system of the 
chromophore caused this shift in the absorption 
maxima. It is known that the intensities and posi- 
tions of peaks depend on the length of the con- 
jugated system: the longer such a system, the 
longer the wavelength of the absorption and the 
larger the extinction coefficient. In the case of col- 
chicine or desacetamidocolchicine, the presence of 
the B-ring does not increase the length of the con- 
jugated system. One possibility is that the ~-- 
electron system of the A- and C-rings in the case of 
AC is prevented from achieving coplanarity, thus 
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Volume 218, number 1 FEBS LETTERS June 1987 
the degree of overlap of the ~r-electron system of 
two rings will be diminished, resulting in the blue 
shift in the absorption spectra. Inspection of the 
structure of AC by dreiding model clearly reveals 
that the A- and C-rings in AC prefer to remain 
above about 60 ° with respect to each other to 
minimize the steric interaction between the C] 
methoxyl and C12 hydrogen (fig.3). In the case of 
colchicine and desacetamidocolchicine the dihedral 
angle defined by the planar A-ring and by carbons 
C7a, Ell,  C12 and C12a of the 'tube-shaped' 
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Fig.3. Multiple conformations of colchicine. Four 
different conformations are possible. Conformation 2
shown above is related to conformation 1 by a boat-boat 
interconversion of the troponoid C-ring. The dihedral 
angle between the plane defined by CTa Cll CI2 and C]2a 
of the C-ring and the planar A-ring is about 53 ° . This 
dihedral angle is reduced to 19 ° in conformation 2. Two 
other conformations of colchicine are possible which are 
related to the shown C-ring boat-boat conformers by 
atropisomerism (about the biaryl bond ~). Although 
such atropisomerism leads to change the chirality of the 
biaryl moieties, there is no change in the dihedral angles. 
(Reproduced with permission from the American 
Chemical Society.) 
methoxytropone, i.e. ring-C, is approx. 53 ° 
(fig.3). Colchicine exists in this conformation both 
in crystal [11,12] and in solution [13]. It has been 
suggested by Detrich et al. [14] as well as by Bane 
et al. [6] that colchicine is converted to conformer 
2 (fig.3) when bound to tubulin. Conformer 2 is 
related to conformer 1 by a boat-boat interconver- 
sion of the troponoid C-ring and has a con- 
siderably smaller dihedral angle i.e. 19 ° (fig.3). 
This reduction of the dihedral angle in conformer 
2 is expected to favour the extended conjugation 
and lead to the red shift in the absorption spectra 
(fig.4A,B). A similar change in conformation is ex- 
pected when AC is bound to tubulin which might 
lead to the red shift in the absorption spectra 
(fig.4C). Recently, it has been demonstrated that 
colchicine, which shows fluorescence when binding 
tubulin, is mainly due to the immobilization of the 
drug in the binding site and this response to im- 
mobilization of colchicine depends in part on the 
partially flexible nature of the drug [15]. Thus, the 
conclusion of the colchicine fluorescence was 
based upon the findings that colchicine shows a 
remarkable fluorescence in pure glycerol and this 
fluorescence decreases with decreasing viscosity of 
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Fig.4. Absorption spectra of colchicine, desacetamido- 
colchicine and AC compound in assembly buffer (1), in 
100% glycerol (2) and in the presence of tubulin (3). In 
(3), the drugs are incubated with a 5-fold excess of 
tubulin (15/zM) in assembly buffer without GTP at 
37°C for 30 min. (A) Colehicine (2.7 x 10 -6 M). •max: 
(1) 353 nm, (2) 358 nm, (3) 354 nm, (B) Desacetamido- 
colchicine (2.8 x 10 -6 M). Amax: (1) 353 nm, (2) 355 nm, 
(3) 356 nm. (C) AC compound (3 × 10 -6 M). Amax: (1) 
341 nm, (2) 348 nm, (3) 346 nm. 
104 
Volume 218, number 1 FEBS LETTERS June 1987 
the medium. We feel that immobilization is also 
partly responsible for the differences in absorption 
maxima of AC and colchicine. Fig.4A shows the 
visible absorption spectra of colchicine when im- 
mobilized to its binding site at tubulin or in pure 
glycerol. In both cases a significant red shift of the 
absorption maxima is observed. Similar red shifts 
in hmax are observed in the case of desacetamido- 
colchicine and AC when they are bound to tubulin 
or present in pure glycerol (fig.4B,C). Partial im- 
mobilization can also be achieved by lowering the 
solution temperature. Thus, it was shown that col- 
chicine fluoresces in glass of ether, isopentane, 
ethanol (5:5:2) at 77 ° and even in ice in a tem- 
perature-dependent manner [16]. Here, we ob- 
served that the absorption maxima of colchicine in 
aqueous solution (25°C) change from 353 to 
355 nm when the temperature is lowered to 4°C. A 
similar red shift is observed in the case of AC. In 
addition to immobilization, lowering of temper- 
ature and addition of glycerol might also favour 
the formation of conformer 2 from conformer 1 
(fig.3). 
3.2. Effect of  the B-ring on photo-induced 
rearrangement of the C-ring 
Ultraviolet irradiation causes the conversion of 
colchicine to ~?- and 7-1umicolchicine [17-20]. This 
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Fig.5. Absorption spectra of colchicine and AC 
compound at different ime intervals during irradiation 
with ultraviolet light. The irradiation experiment was 
carried out as described in section 2. (A) Colchicine, 
isosbestic point, 303 nm. (B) AC compound, isosbestic 
point, 292 nm. 
photo-induced rearrangement occurs at the C-ring 
part of colchicine (fig. 1). It has been reported that 
the positions of the groups present on the C-ring 
affect the rate of the rearrangement reaction [20]. 
A marked effect is observed when the positions of 
the carbonyl and methoxy group in the C-ring are 
interchanged. Thus, isocolchicine shows remark- 
able stability in the presence of ultraviolet light 
[20]. The effect of a B-ring substituent at the C-7 
position has been found to be less significant. In 
fact, when the structures of colchicine and 
lumicolchicine are compared (fig.l), no direct in- 
volvement of the B-ring in the rearrangement is 
noticed. However, here we observed that the 
absence of the B-ring from colchicine results in a 
compound which is very stable towards ultraviolet 
irradiation. Thus the degree of conversion of AC 
into its lumicolchicine derivative is much less than 
that of colchicine. Since the conversion of col- 
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Fig.6. (A) Time kinetics of ultraviolet-induced 
rearrangement of colchicine, desacetamidocolchicine 
and AC compound in 95% ethanol. The ultraviolet 
irradiation experiment was done as described in section 
2. (B) Time course of release of drug from drug-tubulin 
complex (measured by decrease in fluorescence at 
430 nm) during irradiation with ultraviolet light. 2.5/~M 
tubulin was incubated with 5/zM drug at 37°C for 
30 rain. The resultant drug-tubulin complex was 
irradiated for the indicated times and the fluorescence at
430 nm was measured. 
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chicine or its analogs into their corresponding 
lumicolchicine derivative takes place with the loss 
of the chromophore C-ring (which has absorption 
maxima at 350-353 nm) this photochemical con- 
version was followed by measuring the decrease in 
absorbance at 350 nm. Fig.5 shows a typical ir- 
radiation experiment with colchicine and AC. It 
can be seen that AC has much slower breakdown 
than colchicine and 30 min irradiation caused a 33 
and 80o70 decrease in absorbance (at their cor- 
responding Amax), respectively. The isosbestic 
point, which is a proof for the authenticity of a 
compound, has been found to be at 303 and 
292 nm for colchicine and AC, respectively. 
Desacetamidocolchicine, a compound having the 
B-ring but no substitution at the C-7 position, has 
been found to be equally susceptible to colchicine 
(fig.6A). All these irradiation experiments were 
performed by dissolving drug in 95o7o ethanol. 
It has been reported by Wilson and Friedkin [20] 
that the positions of the carbonyl and methoxy 
groups present at the C-ring affect the rate of the 
ultraviolet-induced rearrangement reaction. Thus, 
compared to colchicine, isocolchicine shows 
remarkable stability towards ultraviolet irradia- 
tion. Here we observed that, in comparison to col- 
chicine and desacetamidocolchicine, AC is stable 
towards ultraviolet irradiation. Obviously, it is in- 
teresting to know whether this increased stability 
of AC towards irradiation is due to the presence of 
its isocolchicine form in solution. AC can assume 
the isocolchicine form very easily due to its free 
rotation around the single bond between the A- 
and C-rings. To answer this question we have ir- 
radiated tubulin-AC complex where AC should be 
in the colchicine form (since the isocolchicine form 
does not bind tubulin). The results of such an ex- 
periment are shown in fig.6B. Since AC and col- 
chicine fluoresce only when bound to tubulin, the 
drug-tubulin complexes were irradiated for dif- 
ferent times and the fluorescence was measured 
after each irradiation. Here, it has also been 
observed that AC bound to tubulin is affected 
much less by ultraviolet light compared to col- 
chicine bound to tubulin. Here, the rate of rear- 
rangement of colchicine bound to tubulin is 
slightly lower compared to its free state (fig.6A). 
This could be due to the difference in the environ- 
ment in which the drug is present. In fact, we 
observed that the rate of rearrangement of col- 
chicine into lumicolchicine varies in different 
solvents studied, i.e. water, ethanol, DMSO and 
dioxane, etc. However, no correlation is observed 
between the rate of rearrangement and the solvent 
polarity. 
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